http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_286c8d13b888a550a71ee53946ad5715
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | J.C. Van Berkel Van Berkel Berkel |
| name | Theo J.C. Van Berkel Theo J.C Van Berkel Theo JC Van Berkel |
| given-name | Theo Theo J.C. Van Theo J.C Theo JC Theo J.C. |
| organization-name | From the Division of Biopharmaceutics (M.V.E., M.H., R.B.H., J.K.K., Th.J.C.V.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands; INSERM UMRS525 (D.S., E.N.), Faculté de Médecine, Université Pierre et Marie Curie-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; Institute of Molecular Biology and Biochemistry (W.S.), Center for Molecular Medicine, Medical University of Graz, Austria; Center for Liver, Digestive, and Metabolic Disease (U.J.F.T.... From the Clinical Diabetes Unit, the Department of Internal Medicine (R.W.J., M.-C.B.-M., and S.D.), Medical Faculty, Geneva, Switzerland; the Department of Gastroenterology (A.K.S., B.R., and U.S.), Hannover Medical School, Hannover, Germany; and Gorlaeus Laboratories (R.O. and T.J.C.V.B.), University of Leiden, Leiden, the Netherlands. Division of BioTherapeutics (M.H., M.V.E., T.J.C.V.B.), Leiden Academic Centre for Drug Research, Leiden University, The Netherlands. From the Division of Biopharmaceutics 9R.O., M.H., Y.Z., J.K., T.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands; the Centre for Vascular Research (W.J., I.C.G., L.K.), School of Medical Sciences, University of New South Wales, Sydney, Australia; INSERM U551 (W.L.g., M.J.C., T.H.), Paris, France; Université Pierre et Marie Curie-Paris6 (W.L.G., M.J.C., T.H.), UMR S551 Paris, France; and Centre d’Immunologie de Marseille Luminy (G.C.), Institut... From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands. From Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands (R.B.H., B.L., I.M., S.J.A.K., Y.Z., J.K.K., M.H., T.J.C.V.B., M.V.E.); Department of General Internal Medicine, Endocrinology and Metabolic Disease, Leiden University Medical Center, Leiden, the Netherlands (W.D.H., P.C.N.R.); Department of Pharmacology, Temple University, School of Medicine, Philadelphia, Penn (D.P.); Department of Vascular Medicine, Academic Medical Centre, University of... From National Public Health Institute (R.V., J.M., C.E., M.J.), Department of Molecular Medicine, Biomedicum, Helsinki, Finland; Division of Biopharmaceutics (D.Y., R.B.H. Th.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands. From the Division of Biopharmaceutics (M.V.E., D.Y., R.B.H., T.J.C.V.B.) Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands; Centre for Molecular Medicine and Therapeutics (R.R.S., E.R.J., M.R.H.), Children’s and Women’s Hospital, University of British Columbia, Vancouver, Canada. From the Department of Molecular Medicine (D.Y., M.J., CE., V.M.O.), National Public Health Institute, Biomedicum, Helsinki, Finland; the Division of Biopharmaceutics (R.B.H., T.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands; and the The Departments of General Internal Medicine and Human Genetics (K.W.v.D.), Leiden University Medical Center, Leiden, The Netherlands. From the Division of Biopharmaceutics of the Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands. Present address for P.A.C.’t.H. is the Center for Human and Clinical Genetics, LUMC, Leiden, The Netherlands. Present address for J.T. is Amsterdam Medical Therapeutics, Amsterdam, The Netherlands. From the Division of Biopharmaceutics (J.G., M.V.E., J.T., T.J.C.V.B.), Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands; Department of Pathology and Laboratory Medicine (N.M.), University of North Carolina Medical School, Chapel Hill, NC; and Atherosclerosis Department (G.M.B., P.H.E.G.), GlaxoSmithKline Pharmaceuticals, Stevenage, UK. From the Thrombosis and Haemostasis Laboratory, Department of Clinical Chemistry and Haematology (E.H., B.B., S.J.A.K., M.F.B.G.G., J.-W.N.A.), University Medical Center Utrecht, Crossbeta Biosciences B.V. (B.B., R.S., M.F.B.G.G.), Crystal and Structural Chemistry (Q.Z., P.G.), Bijvoet Center of Biomolecular Research, Utrecht University, Utrecht, and the Division of Biopharmaceutics (M.V.E., T.J.C.VB.), Leiden Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, The... From the Center for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada (R.R.S., N.B., A.H., L.R.B., M.H.K., M.R.H.); Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands (M.V.E., R.B.H., T.J.C.V.B.); Division of Gastroenterology and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pa (F.Z., H.L.C., G.H.R.); Institut Pasteur, Département d’Athérosclérose, INSERM U545,... From the Leiden/Amsterdam Center for Drug Research, Division of Biopharmaceutics, Gorlaeus Laboratories, Leiden, the Netherlands (S.J.A.K., I.M., A.D.H., R.B.H., M.H., T.J.C.V.B., J.K., M.V.E.); Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Laboratory for Clinical Thrombosis and Hemostasis, Maastricht, the Netherlands (H.T.C.); Department of Pharmacology, School of Medicine, Temple University, Philadelphia, Pa (D.P.); Department of Clinical Chemistry and... From the Division of Biopharmaceutics, Cluster BioTherapeutics, Leiden Academic Centre for Drug Research, Gorlaeus Laboratories, The Netherlands. From the Division of Biopharmaceutics (R.O., M.H., K.H., I.M., V.d.W., R.B.H., Y.W., J.K., T.J.C.V.B., and M.V.E.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, The Netherlands; and the Centre d’Immunologie de Marseille Luminy (G.C.), Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Université de la Méditerranée, Marseille, France. From the Division of Biopharmaceutics (Y.Z., M.P., R.B.H., D.Y., L.C.-B., R.O., M.H., T.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands; Department of Molecular Pharmacology (M.K., E.H.-C.), AstraZeneca R&D, Mölndal, Sweden; Department of Pediatrics (A.K.G.), University Medical Center Groningen, The Netherlands; Centre for Vascular Research (W.J.), University of New South Wales, Sydney, Australia; and Centre d'Immunologie de Marseille Luminy (G.C.... From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories (M.V.E., D.Y., R.B.H., J.K.K., M.H., T.J.C.V.B.), Leiden University, Leiden, The Netherlands; Department of Molecular Medicine (C.E., M.J.), National Public Health Institute, Biomedicum, Helsinki, Finland; Department of General Internal Medicine, Endocrinology and Metabolic Diseases (W.d.H., P.C.N.R.), Leiden University Medical Center, Leiden, The Netherlands. From the Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, Sylvius Laboratory, University of Leiden (the Netherlands). From the Department of Clinical Chemistry and Haematology (S.J.A.K., J.A., M.I., T.L., P.J.L., J.-W.N.A.), University Medical Center Utrecht, and Institute of Biomembranes, Utrecht University, the Netherlands; and the Division of Biopharmaceutics (S.J.A.K., M.V.E., R.O., T.J.C.V.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, the Netherlands. From the Division of Biopharmaceutics (R.O., M.H., R.B.H., I.M., Z.L., T.J.C.V.B., M.V.E.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands; From the Center for Liver, Digestive and Metabolic Diseases (J.K., F.K.), Laboratory of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands. From Division of Biopharmaceutics (J.G., V.d.W., M.V.E., R.B.H., E.J.A.W., J.K., T.J.C.V.B.), Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands; Department of Pathology and Laboratory Medicine (N.M.), University of North Carolina Medical School, Chapel Hill, NC; Atherosclerosis Department (M.B., P.H.E.G.), GlaxoSmithKline Pharmaceuticals, Stevenage, UK. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, The Netherlands. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Gorlaeus Laboratory, Leiden, the Netherlands (B.L., G.H.M.V.P., R.B.H., I.M., R.O., J.K., T.J.C.V.B., M.V.E.); Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, Graz, Austria (P.G.C., E.A., B.R., D. Kolb., S.L.-F., D. Kratky); Institute of Molecular Biosciences, University of Graz, Graz, Austria (D. Kolb., G.H., R.Z.). |
Incoming Links
Total number of triples: 132.